You are here
On 13 March 2020, the Commonwealth and all state and territory governments signed the National Partnership on COVID-19 Response, in order to provide financial assistance for the additional costs incurred by health services in responding to the coronavirus disease 2019 (COVID-19) outbreak.
National Hospital Cost Data Collection (NHCDC), Private Hospital Report, Round 22 (Financial year 2017 – 18)17 April 2020
The private sector National Hospital Cost Data Collection (NHCDC) is a voluntary collection that produces a range of hospital cost and activity information by the Australian Refined Diagnosis Related Groups (AR-DRG). This report includes the findings from Round 22 (financial year 2017-18) of the NHCDC for acute admitted care provided by overnight private hospitals.
There are three key publications that support the Tier 2 Non-Admitted Services Classification.
This document provides the technical specifications for how the Independent Hospital Pricing Authority (IHPA) developed the activity based funding models for the service streams to be funded for the National Efficient Price and the National Efficient Cost Determinations 2020–21.
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Cost Determination 2020–21 (Determination):
The Independent Hospital Pricing Authority (IHPA) has developed the Australian Mental Health Care Classification Pricing Feasibility Report 2020–21 to provide an overview of the process undertaken by IHPA to shadow price admitted mental health services using the Australian Mental Health Care Classification (AMHCC) Version 1.0.
The Independent Hospital Pricing Authority (IHPA) is established under the National Health Reform Act 2011 (Cwlth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determination 2020–21 (Determination):
The National Hospital Cost Data Collection (NHCDC) is the primary data collection that the Independent Hospital Pricing Authority (IHPA) relies on to calculate the national efficient price used for the funding of public hospital services. To ensure that the quality of NHCDC data is robust and fit-for-purpose, IHPA commissions an independent financial review to assess whether all participating hospitals have included appropriate costs and patient activity.
The National Hospital Cost Data Collection (NHCDC) Report, infographics and articles present the results from the Round 22 NHCDC (financial year 2017-18).
These documents describe the hospital costs submitted by jurisdictions for the following activity streams:
The purpose of the Assessing Materiality of Changes Proposed to the National Pricing Model document is to outline the process IHPA follows when assessing the materiality of proposed changes to the national pricing models such as the introduction of new adjustments or alternative pricing policy approaches.
The purpose of the Policy is to outline the processes by which IHPA adjusts for instability in the year-on-year price weights and adjustments.
The Pricing Framework for Australian Public Hospital Services 2020-21 (the Pricing Framework) is the key strategic document underpinning the National Efficient Price (NEP) and National Efficient Cost (NEC) Determinations for the financial year 2020-21.
IHPA has issued the Pricing Framework prior to releasing the NEP20 and NEC20 Determinations, which will be publicly available in March 2020, with the intention of providing an additional layer of transparency and accountability.
There is a growing discussion in Australia and internationally about the need to increase focus on delivering value-based health care with a focus on patient outcomes and experience.
IHPA’s Pricing Guidelines and the National Health Reform Agreement include provisions for IHPA to consider the impact on its work of evidence‑based, effective new technologies and innovations in models of health care.
The Fundamental Review of the National Efficient Price (NEP) was commissioned by IHPA to review the methodology underpinning the National Pricing Model. IHPA engaged Ernst & Young (EY), KPMG and PricewaterhouseCoopers (PwC) to independently perform the review in close consultation with IHPA’s advisory committees.
This report was prepared in accordance with the requirements of the National Health Reform Act 2011 and section 46 of the Public Governance, Performance and Accountability Act 2013. The report includes IHPA's audited Financial Statements, as required by section 42 of the Public Governance, Performance and Accountability Act.